Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase (BTK) Inhibitor
Acalabrutinib for Lymphoma
Recruiting1 awardPhase 1 & 2
Boston, Massachusetts
This trial is testing Acalabrutinib, a drug used in other cancers, to see if it can help people with a type of brain cancer that hasn't responded to other treatments. The drug works by stopping the cancer cells from growing.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.